CITIGROUP INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$35,750,000
+22.4%
1,536,875
-16.3%
0.03%
+37.5%
Q1 2018$29,204,000
-38.7%
1,835,907
-19.4%
0.02%
-36.8%
Q4 2017$47,650,000
+75.5%
2,278,615
+20.0%
0.04%
+72.7%
Q3 2017$27,145,000
+14.8%
1,898,117
+39.3%
0.02%
+4.8%
Q2 2017$23,643,000
-6.9%
1,362,232
-40.9%
0.02%
-8.7%
Q1 2017$25,390,000
+63.8%
2,305,404
+115.9%
0.02%
+64.3%
Q4 2016$15,504,000
-48.1%
1,067,768
-12.4%
0.01%
-48.1%
Q3 2016$29,846,000
+27.5%
1,218,570
+4.4%
0.03%
+12.5%
Q2 2016$23,410,000
-6.2%
1,166,691
+23.0%
0.02%
-14.3%
Q1 2016$24,970,000
-59.8%
948,269
+54.7%
0.03%
-54.8%
Q4 2015$62,079,000
+2.9%
613,089
+80.6%
0.06%
+10.7%
Q3 2015$60,318,000
+40.0%
339,515
+74.9%
0.06%
+47.4%
Q2 2015$43,092,000
+9.9%
194,135
-2.2%
0.04%
+2.7%
Q1 2015$39,206,000
+158.2%
198,452
+87.5%
0.04%
+184.6%
Q4 2014$15,187,000
+111.6%
105,861
+93.7%
0.01%
+116.7%
Q3 2014$7,178,000
-3.9%
54,656
-7.3%
0.01%
-14.3%
Q2 2014$7,467,000
-46.9%
58,938
-44.7%
0.01%
-53.3%
Q1 2014$14,055,000
-9.0%
106,662
-19.1%
0.02%
+7.1%
Q4 2013$15,450,000
+7.1%
131,886
-4.5%
0.01%0.0%
Q3 2013$14,426,000
+49.1%
138,053
+22.6%
0.01%
+40.0%
Q2 2013$9,676,000112,5690.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders